Related Experiment Video
Updated: Dec 21, 2025
08:34
Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
7.6K
COVID-19 and pulmonary hypertension.
1Department of Pulmonary Medicine, Respiratory Institute, Cleveland Clinic.
Cleveland Clinic Journal of Medicine
|May 13, 2020
Summary
Few cases of COVID-19 in pulmonary hypertension (PH) patients are reported. Factors like social distancing, disease rarity, and under-testing may influence these low numbers, alongside PH pathophysiology and treatments.
Area of Science:
- Cardiology
- Pulmonology
- Infectious Diseases
Background:
- Pulmonary hypertension (PH) is a progressive vascular disease leading to right heart failure.
- COVID-19 is a novel respiratory illness with significant global impact.
- Limited data exist on COVID-19 outcomes in patients with pre-existing PH.
Purpose of the Study:
- To explore the observed low incidence of COVID-19 in patients with pulmonary hypertension.
- To discuss potential factors influencing the reporting and occurrence of COVID-19 in PH patients.
Main Methods:
- Review of existing literature and case reports.
- Analysis of epidemiological factors potentially affecting disease reporting.
- Consideration of pathophysiological and therapeutic interactions between PH and COVID-19.
Main Results:
- A low number of reported COVID-19 cases in PH patients has been noted.
- Several factors may contribute to this observation, including behavioral changes and diagnostic limitations.
- The interplay between PH, its treatments, and SARS-CoV-2 infection requires further investigation.
Conclusions:
- The low reported incidence of COVID-19 in PH patients warrants cautious interpretation.
- Further research is crucial to understand the complex relationship between pulmonary hypertension and COVID-19.
- Investigating the impact of PH pathophysiology and treatments on COVID-19 is essential.
Related Concept Videos
01:30Pulmonary Hypertension: Classification and Pathogenesis
489
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
489
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
370
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
370
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
502
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
502
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.4K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.4K
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
01:29Pulmonary Embolism I: Introduction
409
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
409